2. Search Result
Search Result
Results for "

At TK

" in MedChemExpress (MCE) Product Catalog:

77

Inhibitors & Agonists

1

Fluorescent Dyes

1

Biochemical Assay Reagents

4

Peptides

5

Natural
Products

4

Isotope-Labeled Compounds

8

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-N0377
    Liquiritigenin
    Maximum Cited Publications
    14 Publications Verification

    4',7-Dihydroxyflavanone

    		 Estrogen Receptor/ERR Neurological Disease Inflammation/Immunology Cancer
    Liquiritigenin, a flavanone isolated from Glycyrrhiza uralensis, is a highly selective estrogen receptor β (ERβ) agonist with an EC50 of 36.5 nM for activation of the ERE tk-Luc.
    Liquiritigenin
  • HY-107430
    Oxythiamine
    3 Publications Verification

    Hydroxythiamin

    		 Apoptosis Endogenous Metabolite Cancer
    Oxythiamine (Hydroxythiamin), an analogue of anti-metabolite, can suppress the non-oxidative synthesis of ribose and induce cell apoptosis. Oxythiamine is a thiamine antagonist and inhibits transketolase (TK). Oxythiamine inhibits cancer cell apoptosis and inhibits cell proliferation .
    Oxythiamine
  • HY-W008491
    TK-112690

    		Phosphorylase Inflammation/Immunology Cancer
    TK-112690 is a UPP1 inhibitor. TK-112690 inhibits murine small intestinal uridine phosphorylase (UPase) with an IC50 of 12.5 μM and human small intestinal UPase with an IC50 of 20.0 μM in vitro. TK-112690 increases plasma uridine concentration in mice. TK-112690 can be used for the study of cancer and pulmonary fibrosis .
    TK-112690
  • HY-122903
    TK216
    5+ Cited Publications

    		 DNA/RNA Synthesis Cancer
    TK216 is an orally active and potent E26 transformation specific (ETS) inhibitor . TK216 directly binds EWS-FLI1 and inhibits EWS-FLI1 protein interactions. TK216 blocks the binding between EWS-FLI1 and RNA helicase A. TK216 has anticancer activity .
    TK216
  • HY-112889B
    Oxythiamine diphosphate ammonium
    1 Publications Verification

    		 Transketolase Metabolic Disease
    Oxythiamin diphosphate ammonium is a potent transketolase (TK) inhibitor .
    Oxythiamine diphosphate ammonium
  • HY-16339
    N3PT
    2 Publications Verification

    N3-pyridyl thiamine

    		 Transketolase Cancer
    N3PT (N3-pyridyl thiamine) is a potent and selective transketolase inhibitor. N3PT is pyrophosphorylated and then binds to transketolase with an Kd value of 22 nM (Apo-TK, transketolase lacking bound thiamine) .
    N3PT
  • HY-107430A
    Oxythiamine chloride hydrochloride
    3 Publications Verification

    Hydroxythiamine chloride hydrochloride

    		 Apoptosis Endogenous Metabolite Cancer
    Oxythiamine (Hydroxythiamine) chloride hydrochloride, an analogue of anti-metabolite, can suppress the non-oxidative synthesis of ribose and induce cell apoptosis. Oxythiamine chloride hydrochloride is a thiamine antagonist and inhibits transketolase (TK). Oxythiamine chloride hydrochloride inhibits cancer cell apoptosis and inhibits cell proliferation .
    Oxythiamine chloride hydrochloride
  • HY-W342664
    2'-Deoxy-2'-fluoro-5-iodouridine

    FIRU

    		 Nucleoside Antimetabolite/Analog HSV Cancer
    2'-Deoxy-2'-fluoro-5-iodouridine (FIRU) is a nucleoside analog. When labeled with 123I, 2'-Deoxy-2'-fluoro-5-iodouridine accumulates highly selectively in tumors expressing the HSV1-tk gene. Radiolabeled 2'-Deoxy-2'-fluoro-5-iodouridine enables imaging of adenovirus-mediated HSV1-tk suicide gene transfer .
    2'-Deoxy-2'-fluoro-5-iodouridine
  • HY-112889
    Oxythiamine diphosphate

    		Transketolase Metabolic Disease
    Oxythiamin diphosphate is a potent transketolase (TK) inhibitor .
    Oxythiamine diphosphate
  • HY-17422S1
    Acyclovir-d4

    Aciclovir-d4; Acycloguanosine-d4

    		 Isotope-Labeled Compounds HSV Bacterial Apoptosis Antibiotic Infection Cancer
    Acyclovir-d4 is the deuterium labeled Acyclovir. Acyclovir (Aciclovir) is a guanosine analogue and an orally active antiviral agent. Acyclovir inhibits HSV-1 (IC50 of 0.85 μM), HSV-2 (IC50 of 0.86 μM) and varicella-zoster virus. Acyclovir can be phosphorylated by viral thymidine kinase (TK), and Acyclovir triphosphate interferes with viral DNA polymerization through competitive inhibition with guanosine triphosphate and obligatory chain termination . Acyclovir prevents bacterial infections during induction therapy for acute leukaemia .
    Acyclovir-d4
  • HY-151483
    TK-129

    		Wnt Histone Demethylase Cardiovascular Disease
    TK-129 is an orally active, low-toxicity, potent KDM5B inhibitor (with high affinity; IC50=44 nM). TK-129 exerts cardioprotective effects by inhibiting KDM5B and blocking the KDM5B-associated Wnt pathway. TK-129 reduces ang II-induced activation of cardiac fibroblasts in vitro and reduces isoprenaline-induced myocardial remodelling and fibrosis in vivo. TK-129 can be used in studies of cardiovascular disease .
    TK-129
  • HY-139731
    Transketolase-IN-1

    		Transketolase Herbicide Others
    Transketolase-IN-1 is a transketolase inhibitor and a herbicide. Transketolase-IN-1 inhibits weed growth and exhibits safety for maize and wheat at specified application rates. Transketolase-IN-1 can be used for the research of weed control in wheat and maize fields .
    Transketolase-IN-1
  • HY-151604
    Transketolase-IN-3

    		Transketolase Others
    Transketolase-IN-3 is a potent transketolase (TK) inhibitor. Transketolase-IN-3 has herbicidal activity and has inhibitory effects against Digitaria sanguinalis (DS) and Amaranthus retroflexus (AR). Transketolase-IN-3 can be used for the research of herbicides .
    Transketolase-IN-3
  • HY-114327
    D-Ribose 1,5-diphosphate

    R15P

    		 Endogenous Metabolite Drug Intermediate Biochemical Assay Reagents Others
    D-Ribose 1,5-diphosphate (R15P) is a metabolic intermediate and enzyme substrate. Purified Tk-E2b2 converts D-Ribose 1,5-diphosphate into Ribulose-1,5-bisphosphate, with a specific activity of 32.3 μmol min -1 mg -1[1] .
    D-Ribose 1,5-diphosphate
  • HY-D2415
    BODIPY-FL staurosporine

    		Fluorescent Dye Others
    BODIPY-FL staurosporine (Compound 8a) is a fluorescence probe based on staurosporine, exhibiting high specificity towards tyrosine kinases (TK) and tyrosine kinase-like (TKL) family kinases. BODIPY-FL staurosporine has the potential to develop binding assays for kinases that are not recommended for use with Kinase Tracer 236, such as PIM3, CDC42BPG, MAP2K7, TXK, and SIK3. BODIPY-FL staurosporine can be a powerful tool for analyzing kinase selectivity in kinase drug discovery .
    BODIPY-FL staurosporine
  • HY-122903B
    (+)-TK216

    		DNA/RNA Synthesis Cancer
    (+)-TK216 is an enantiomer of TK216 (HY-122903). TK216 is an orally active and potent E26 transformation specific (ETS) inhibitor .
    (+)-TK216
  • HY-P1079
    ω-Agatoxin TK

    		Calcium Channel Neurological Disease
    ω-Agatoxin TK, a peptidyl toxin of the venom of Agelenopsis aperta, is a potent and selective P/Q type Ca 2+ channel blocker. ω-Agatoxin TK inhibits the high K + depolarisation-induced rise in internal Ca 2+ in cerebral isolated nerve endings with an IC50 of of 60 nM. ω-Agatoxin TK has no effect on L-type, N-type, or T-type calcium channels .
    ω-Agatoxin TK
  • HY-117143
    TK05
    1 Publications Verification

    		 Glutathione S-transferase Inflammation/Immunology
    TK05 is a potent and selective inhibitor of leukotriene C4 synthase (LTC4S) with an IC50 of 95 nM .
    TK05
  • HY-128710
    2'-Fluorothymidine

    2'-​Deoxy-​2'-​fluoro-​5-​Methyluridine

    		 Nucleoside Antimetabolite/Analog Cancer
    2'-Fluorothymidine (2'-Fluoro-2'-deoxythymidine) is a nucleoside analog and hCNT inhibitor, with an IC50 of 1.1 μM against hCNT1 and an IC50 of 9.7 μM against hCNT3. 2'-Fluorothymidine undergoes phosphorylation by cytosolic thymidine kinase (TK1) and mitochondrial thymidine kinase (TK2). 2'-Fluorothymidine acts as a backbone stabilizer in oligonucleotide synthesis and can also form radiolabeled candidates. 2'-Fluorothymidine is applicable in tumor-related research .
    2'-Fluorothymidine
  • HY-E70075
    α-Glycerophosphate Dehydrogenase-Triosephosphate

    GDH-TIM; GDH-TPI

    		 Transketolase Metabolic Disease
    α-Glycerophosphate Dehydrogenase-Triosephosphate (GDH-TIM) is an enzyme mixture composed of glycerol phosphate dehydrogenase (GDH) and triphosphate isomerase (TIM). α-Glycerophosphate Dehydrogenase-Triosephosphate can be used to determine the activity of transketolase (TK) in hemolytic substances of red blood cells to evaluate vitamin B deficiency .
    α-Glycerophosphate Dehydrogenase-Triosephosphate
  • HY-W353804
    2′-Deoxy-β-L-uridine

    		Nucleoside Antimetabolite/Analog Infection
    2'-Deoxy-β-L-uridine is a nucledside analogue and a specific substrate for the viral enzyme, shows no stereospecificity against herpes simplex 1 (HSV1) thymidine kinase (TK). 2′-Deoxy-β-L-uridine exerts antiviral activity via the interation of 5'-triphosphates with the viral DNA polymerase .
    2′-Deoxy-β-L-uridine
  • HY-118304B
    AKN-028 acetate

    		FLT3 Apoptosis Caspase Cancer
    AKN-028 acetate, a novel tyrosine kinase (TK) inhibitor, is a potent, orally active FMS-like receptor tyrosine kinase 3 (FLT3) inhibitor with an IC50 value of 6 nM. AKN-028 acetate inhibits FLT3 autophosphorylation. AKN-028 acetate induces dose-dependent cytotoxic response (mean IC50=1 μM). AKN-028 acetate induces apoptosisby activation of caspase 3. AKN-028 acetate can be used in research of acute myeloid leukemia (AML).
    AKN-028 acetate
  • HY-122903S
    TK216-d4

    		Isotope-Labeled Compounds DNA/RNA Synthesis Cancer
    TK216-d4 is the deuterium labeled TK216 (HY-122903). TK216 is an orally active and potent E26 transformation specific (ETS) inhibitor . TK216 directly binds EWS-FLI1 and inhibits EWS-FLI1 protein interactions. TK216 blocks the binding between EWS-FLI1 and RNA helicase A. TK216 has anticancer activity .
    TK216-d4
  • HY-107430B
    Oxythiamine chloride

    Hydroxythiamine chloride

    		 Apoptosis Cancer
    Oxythiamine (Hydroxythiamine) chloride, an analogue of anti-metabolite, can suppress the non-oxidative synthesis of ribose and induce cell apoptosis. Oxythiamine is a thiamine antagonist and inhibits transketolase (TK). Oxythiamine chloride inhibits cancer cell apoptosis and inhibits cell proliferation .
    Oxythiamine chloride
  • HY-173571
    TK-685

    		SHP2 Apoptosis Cancer
    TK-685 is an orally active, selective, and allosteric SHP2 inhibitor with an IC50 of 2.1 nM. TK-685 inhibits esophageal cancer cell proliferation and induced apoptosis by targeting SHP2-mediated AKT and ERK signaling pathways .
    TK-685
  • HY-151259
    TK4b

    		JAK Cancer
    TK4b is a dual JAK2/3 inhibitor with human JAK2 and JAK3 IC50s of 19.40 nM and 18.42 nM, respectively. TK4b can be used for the research of leukemia and myelofibrosis .
    TK4b
  • HY-107430AR
    Oxythiamine chloride hydrochloride (Standard)

    Hydroxythiamine chloride hydrochloride (Standard)

    		 Apoptosis Reference Standards Endogenous Metabolite Cancer
    Oxythiamine chloride hydrochloride (Standard) is the analytical standard of Oxythiamine chloride hydrochloride (HY-107430A). This product is intended for research and analytical applications. Oxythiamine (Hydroxythiamine) chloride hydrochloride, an analogue of anti-metabolite, can suppress the non-oxidative synthesis of ribose and induce cell apoptosis. Oxythiamine chloride hydrochloride is a thiamine antagonist and inhibits transketolase (TK). Oxythiamine chloride hydrochloride inhibits cancer cell apoptosis and inhibits cell proliferation .
    Oxythiamine chloride hydrochloride (Standard)
  • HY-122903A
    (-)-TK216

    		DNA/RNA Synthesis Cancer
    (-)-TK216 is an enantiomer of TK216 (HY-122903). TK216 is an orally active and potent E26 transformation specific (ETS) inhibitor. (-)-TK216 has anti-cancer activity .
    (-)-TK216
  • HY-146471
    EGFR-IN-51

    		EGFR Apoptosis Cancer
    EGFR-IN-51 (Compound 6) is a potent EGFR inhibitor with IC50 values of 0.493, 102.60 and 461.63 µM against EGFR, EGFR L858R-TK and EGFR T790M-TK, respectively. EGFR-IN-51 shows cytotoxic activity against cancer cell lines and induces apoptosis .
    EGFR-IN-51
  • HY-P1768
    Urechistachykinin I

    Uru-TK I

    		 Bacterial Infection
    Urechistachykinin I (Uru-TK I), an invertebrate tachykinin-related peptides (TRPs) isolated from echiuroid worms, shows antimicrobial activities without a hemolytic effect .
    Urechistachykinin I
  • HY-169436
    Lon-TK

    		PD-1/PD-L1
    Lon-TK is a glycolysis inhibitor + linker conjugate of LTB (HY-169434). LTB is an intelligent responsive prodrug that connects Lonidamine (Lon) (HY-B0486) and a PD-L1 inhibitor (BMS-1, HY-19991) through a thioketal linker. It significantly inhibits the glycolytic metabolism of tumor cells and blocks the PD-1/PD-L1 immune escape pathway. Lon-TK shows potential for application in photodynamic-enhanced immunotherapy research .
    Lon-TK
  • HY-144445
    NSC114126

    		EGFR Cancer
    NSC114126 is a potent and orally active inhibitor of EGFR tyrosine kinase (EGFR-TK). NSC114126 has strong antiproliferative activities. NSC114126 has the potential for the research of cancer diseases .
    NSC114126
  • HY-178442
    EGFR-IN-179

    		EGFR Cancer
    EGFR-IN-179 (Compound 8d) is an EGFR inhibitor (IC50: 0.068 μM for EGFR L858R/T790M/C797S; 2.56 μM for EGFR-WT-TK). EGFR-IN-179 has anticancer activity against non-small cell lung cancer .
    EGFR-IN-179
  • HY-149022
    HSV-1/HSV-2-IN-1

    		HSV Orthopoxvirus Infection
    HSV-1/HSV-2-IN-1 (compound 7d) is a HSV-1 and HSV-2 inhibitor, with EC50s of 7.6, 7.6, 4, and 12 μM for HSV-1 (KOS), HSV-2 (G), HSV-1 TK - KOS ACV r and vaccinia virus in human embryonic lung fibroblast cell cultures .
    HSV-1/HSV-2-IN-1
  • HY-118304
    AKN-028

    		FLT3 Apoptosis Caspase Cancer
    AKN-028, a novel tyrosine kinase (TK) inhibitor, is a potent, orally active FMS-like receptor tyrosine kinase 3 (FLT3) inhibitor with an IC50 value of 6 nM. AKN-028 inhibits FLT3 autophosphorylation. AKN-028 induces dose-dependent cytotoxic response (mean IC50=1 μM). AKN-028 induces apoptosisby activation of caspase 3. AKN-028 can be used in research of acute myeloid leukemia (AML) .
    AKN-028
  • HY-173573
    TK-684

    		Apoptosis SHP2 Cancer
    TK-684 is a potent and selective allosteric SHP2 inhibitor with IC50 values of 2.1, ＞1000 nM for SHP2 WT, SHP22 PTP, respectively. TK-684 inhibits cell proliferation and induces apoptosis. TK-684 decreases the protein expression of p-AKT, p-ERK .
    TK-684
  • HY-126218
    HSV-TK substrate

    		HSV Cancer
    HSV-TK substrate is a substrate for HSV-TK, and induces multi-log cytotoxicity in HSV-TK-expressing and bystander cells. HSV-TK substrate shows antitumor activity .
    HSV-TK substrate
  • HY-158762
    TK-642

    		SHP2 Cancer
    TK-642 is a highly active, selective, orally activity SHP2 inhibitor based on pyrazole and pyrazine (IC50=2.7 nmol/L). TK-642 can effectively inhibit the proliferation of esophageal carcinoma cells and induce cell apoptosis. TK-642 can be used in the study of esophageal cancer .
    TK-642
  • HY-161927
    EGFR-TK-IN-4

    		EGFR Apoptosis Cancer
    EGFR-TK-IN-4 (compound 10k) is a potent and selective EGFR-TK inhibitor. EGFR-TK-IN-4 can induce apoptosis . EGFR-TK-IN-4 has antitumor activity .
    EGFR-TK-IN-4
  • HY-158018
    EGFR-TK-IN-2

    		EGFR Cancer
    EGFR-TK-IN-2 (compound 10b) is EGFR-TK inhibitor with the IC50 of 0.16 μM. EGFR-TK-IN-2 inhibits cell growth .
    EGFR-TK-IN-2
  • HY-169435
    TK-OH

    		Drug Intermediate Cancer
    TK-OH is the linker of LTB (HY-169434). TK-OH can be used for the research of cancers .
    TK-OH
  • HY-172156
    EGFR-TK-IN-5

    		EGFR Cancer
    EGFR-TK-IN-5 (Compound NCE 2) is a thiazolyl-pyrazoline derivative. EGFR-TK-IN-5 exhibits strong inhibitory activity and stability against EGFR. EGFR-TK-IN-5 can be used in the study of cancer .
    EGFR-TK-IN-5
  • HY-163860
    EGFR-TK-IN-3

    		EGFR Cancer
    EGFR-TK-IN-3 (3) is an EGFR TK inhibitor, with an IC50 of 2.33 μM against Erlotinib (HY-50896)-resistant A549 cells .
    EGFR-TK-IN-3
  • HY-RS23490
    Tk1 Rat Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others

    Tk1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Tk1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Tk1 Rat Pre-designed siRNA Set A
    Tk1 Rat Pre-designed siRNA Set A
  • HY-RS14556
    TK1 Human Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others

    TK1 Human Pre-designed siRNA Set A contains three designed siRNAs for TK1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    TK1 Human Pre-designed siRNA Set A
    TK1 Human Pre-designed siRNA Set A
  • HY-RS24088
    Tk2 Rat Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others

    Tk2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Tk2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Tk2 Rat Pre-designed siRNA Set A
    Tk2 Rat Pre-designed siRNA Set A
  • HY-RS17628
    Tk2 Mouse Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others

    Tk2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Tk2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Tk2 Mouse Pre-designed siRNA Set A
    Tk2 Mouse Pre-designed siRNA Set A
  • HY-RS14557
    TK2 Human Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others

    TK2 Human Pre-designed siRNA Set A contains three designed siRNAs for TK2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    TK2 Human Pre-designed siRNA Set A
    TK2 Human Pre-designed siRNA Set A
  • HY-W008907
    5'-O-Tritylthymidine

    5-OTT

    		 Apoptosis Cancer
    5'-O-Tritylthymidine is an inhibitor of TK-2 and inhibits angiogenesis . 5'-O-Tritylthymidine targets FAK-Mdm-2 interactions, decreasing cell viability and increasing apoptosis.
    5'-O-Tritylthymidine
  • HY-151258
    TK4g

    		JAK Cancer
    TK4g is a Janus kinase (JAK) inhibitor with the IC50 values of 12.61 nM and 15.80 nM for JAK2 and JAK3, respectively. TK4g can be used in lymphoid-derived diseases and leukemia cancer research .
    TK4g

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: